ICMR, Pfizer collaborate to work on antimicrobial resistance

2018-02-01 06:40:25

ICMR and Pfizer have collaborated to set up a Centre to Combat Antimicrobial Resistance in New Delhi.By Team ABLEThe Indian Council of Medical Research (ICMR) and biopharma giant Pfizer have collaborated to set up a centre to address the growing threat of antimicrobial resistance in India. The Centre to Combat Antimicrobial Resistance in New Delhi will be set up as a part of memorandum of understa

Read more

Elsevier welcomes six biotech and pharma start-ups to The Hive

2018-02-01 06:37:39

Start-ups working on a range of  technologies and discoveries, from AI to immunotherapy, receive complimentary access to Elsevier\'s information solutions to accelerate innovation. By Team ABLEElsevier, the global information analytics business specializing in science and health, has announced that six start-up companies have been selected from more than 150 global applicants for The Hive, El

Read more

High levels of antibiotic resistance found worldwide: reveals WHO’s new data

2018-02-01 06:31:16

WHO\'s new Global Antimicrobial Surveillance System reveals widespread occurrence of antibiotic resistance among 500,000 people with suspected bacterial infections across 22 countries.By Team ABLEWHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries.WHO’s new Global

Read more

C-CAMP\'s Meet the Investors Series to be held on Feb 15th at New Delhi

2018-02-01 06:28:52

This series will give the bio-entrepreneurs, who are looking to raise funding, an opportunity to pitch their business proposal to a panel of investors.By Team ABLE‘Meet the Investors Series’ is a series of quarterly meetings between investors and start-up bio-entrepreneurs. This series will give the bio-entrepreneurs, who are looking to raise funding, an opportunity to pitch their business pro

Read more

Economic Survey of India 2017-18 has a chapter on \"Transforming Science and Technology in India\"

2018-01-30 09:39:11

Prof. K. VijayRaghavan, DBT secretary tweeted that The Economic Survey has a detailed section on science which is quite remarkable. The chapter mentions that about three-fifths of the public investment is spread over the key government science funding agencies like At omic Energy, Space, Earth Sciences, Science and Technology and Biotechnology. Given the country’s severe health challenges, the l

Read more

Sanofi to acquire Belgian biotech firm Ablynx for USD 4.8 billion

2018-01-30 08:34:08

By acquiring Ablynx, Sanofi will be expanding its portfolio of drugs in rare blood disorders. By Team ABLEFrance’s Sanofi has announced that the company has reached a deal to acquire Belgian biotech firm Ablynx that values the firm at USD 4.8 billion, beating out Danish rival Novo Nordisk for the nano-drug maker.Novo Nordisk earlier this month made a 2.6-billion-euro offer to buy the firm that i

Read more

Mylan, Biocon receive positive CHMP opinion for Semglee

2018-01-30 08:33:17

Mylan and Biocon have received European Medicines Agency\'s positive opinion, recommending approval of Semglee, insulin glargine, a long-acting insulin analog used in the treatment of diabetes mellitusBy Team ABLEGlobal biopharmaceutical companies, Mylan N.V. and Biocon Ltd. have announced that the European Medicines Agency\'s Committee for Medicinal Products for Human Use (CHMP) has issued a posi

Read more

Cipla, Strides Shasun ship generic versions of Gilead Sciences’ HIV drug Viread

2018-01-30 08:32:32

Indian pharmaceutical companies, Cipla and Strides Shasun have started shipping generic versions of Gilead Sciences’ HIV drug Viread after its patent protection expired last week.By Team ABLEIndian pharmaceutical companies, Cipla and Strides Shasun have started shipping generic versions of Gilead Sciences’ HIV drug Viread after its patent protection expired last week.Cipla said that it has rec

Read more

Ratan Tata invests in medtech startup Axio

2018-01-30 08:31:40

Axio Biosolutions raises $7.4mn in Series B round from Ratan Tata’s RNT Capital along with existing investors Accel Partners and IDG Ventures India. By Team ABLEAxio Biosolutions, the first Indian company to launch an emergency haemostat for trauma care, has raised $7.4 million in a Series B funding round led by Ratan Tata’s RNT Capital along with existing investors Accel Partners and IDG Vent

Read more

Biocon clocks Rs 1092 crore in Q3FY18 revenue

2018-01-29 08:14:53

In this quarter, Biocon has accomplished a major milestone of obtaining USFDA approval for biosimilar Trastuzumab partnered with Mylan; and another highlight was the new strategic partnership with SandozBy Team ABLEAsia\'s premier biopharmaceuticals company Biocon Ltd has announced its consolidated financial results for the fiscal third quarter ended on December 31st, 2017.Commenting on the highli

Read more